ID

31508

Beschrijving

Escitalopram in the Treatment of Postpartum Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01527474

Link

https://clinicaltrials.gov/show/NCT01527474

Trefwoorden

Versies (1)
  1. 30-08-18 30-08-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

30 augustus 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Postpartum Depression NCT01527474

Engels

Eligibility Postpartum Depression NCT01527474

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
female between the ages of 19 to 40 years of age
Beschrijving

Gender | Age

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
given birth in the last 6 months
Beschrijving

Birth Recently

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005615
UMLS CUI [1,2]
C0332185
not currently breastfeeding
Beschrijving

Breast Feeding Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0006147
UMLS CUI [1,2]
C0332197
meet criteria for major depressive disorder as per the diagnostic and statistical manual of mental disorders, 4th edition (dsm-iv tr)
Beschrijving

Major Depressive Disorder

Datatype

boolean

Alias
UMLS CUI [1]
C1269683
montgomery-asberg depression rating scale (madrs) score greater than or equal to 25 at enrolment
Beschrijving

Montgomery-Asberg Depression Rating Scale Questionnaire

Datatype

boolean

Alias
UMLS CUI [1]
C4054475
able to read and write english
Beschrijving

Able to read English Language | Able to write English Language

Datatype

boolean

Alias
UMLS CUI [1,1]
C0586740
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0584993
UMLS CUI [2,2]
C0376245
sign written informed consent to participate in the study.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
have a significant risk of suicide according to the investigator's opinion or presents a score of 5 or greater on item 10 (suicidal thoughts) of of the madrs
Beschrijving

At risk for suicide | Feeling suicidal MADRS

Datatype

boolean

Alias
UMLS CUI [1]
C0563664
UMLS CUI [2,1]
C0424000
UMLS CUI [2,2]
C4054475
meets dsm-iv-tr criteria for past or current manic or hypomanic episode, past or current psychotic symptoms or disorder, and/or has a history of drug or alcohol abuse/dependence within the last 6 months
Beschrijving

Manic episode | Hypomanic episode | Psychotic symptom | Psychotic Disorders | Substance Use Disorders | Substance Dependence

Datatype

boolean

Alias
UMLS CUI [1]
C0349208
UMLS CUI [2]
C1396834
UMLS CUI [3]
C0871189
UMLS CUI [4]
C0033975
UMLS CUI [5]
C0038586
UMLS CUI [6]
C0038580
uses the following disallowed recent or concomitant medication within the specified time periods - any antidepressant or any drug used for augmentation of antidepressant action within the last 2 weeks (5 weeks for fluoxetine) prior to baseline, any benzodiazepines or other anxiolytics within the last week prior to baseline, any non-benzodiazepine hypnotics within the last week prior to baseline, oral antipsychotics within 2 weeks or depot antipsychotics within 6 months prior to baseline, serotonergic medicinal products (for example triptans, tryptophan, tramadol) within the last week prior to baseline, psychoactive herbal remedies (for example st. johns wort, kava kava, valerian, gingko biloba) within the last 2 weeks prior to baseline, any other drug with potential psychotropic effects within the last 2 weeks prior to baseline, any anticonvulsant drug within the last 2 weeks prior to baseline, or any investigational product within 3 months prior to baseline
Beschrijving

Antidepressive Agents | Fluoxetine | Benzodiazepines | Anti-Anxiety Agents | Sedative hypnotics (non-benzodiazepines) | Antipsychotic Agents Oral | Antipsychotic Agents Depot | Serotonin Agents | Triptans | Tryptophan | Tramadol | Herbal medicine Psychoactive | ST. JOHN'S WORT EXTRACT | Kava preparation | Valerian | Ginkgo biloba extract | Psychotropic Drugs | Anticonvulsants | Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0003289
UMLS CUI [2]
C0016365
UMLS CUI [3]
C0005064
UMLS CUI [4]
C0040616
UMLS CUI [5]
C3854290
UMLS CUI [6,1]
C0040615
UMLS CUI [6,2]
C1527415
UMLS CUI [7,1]
C0040615
UMLS CUI [7,2]
C0086129
UMLS CUI [8]
C0242701
UMLS CUI [9]
C1567966
UMLS CUI [10]
C0041249
UMLS CUI [11]
C0040610
UMLS CUI [12,1]
C2240391
UMLS CUI [12,2]
C0682880
UMLS CUI [13]
C0813171
UMLS CUI [14]
C0939882
UMLS CUI [15]
C0795674
UMLS CUI [16]
C0772125
UMLS CUI [17]
C0033978
UMLS CUI [18]
C0003286
UMLS CUI [19]
C0013230
is currently receiving formal cognitive or behavioural therapy, systematic psychotherapy, or plans to initiate such therapy during the study
Beschrijving

Cognitive Therapy | Behavior Therapy | Psychotherapy systematic | Cognitive Therapy Planned | Behavior Therapy Planned | Psychotherapy systematic Planned

Datatype

boolean

Alias
UMLS CUI [1]
C0009244
UMLS CUI [2]
C0004933
UMLS CUI [3,1]
C0033968
UMLS CUI [3,2]
C0220922
UMLS CUI [4,1]
C0009244
UMLS CUI [4,2]
C1301732
UMLS CUI [5,1]
C0004933
UMLS CUI [5,2]
C1301732
UMLS CUI [6,1]
C0033968
UMLS CUI [6,2]
C0220922
UMLS CUI [6,3]
C1301732
current depressive symptoms of the patient are considered by the investigator to have been resistant to two well-conducted antidepressant treatments of at least 6 weeks duration
Beschrijving

Depressive Symptoms | Resistant to Antidepressant therapy Quantity

Datatype

boolean

Alias
UMLS CUI [1]
C0086132
UMLS CUI [2,1]
C0332325
UMLS CUI [2,2]
C1096649
UMLS CUI [2,3]
C1265611
has a serious illness or serious sequelae thereof, including liver or renal insufficiency, or a cardiovascular, pulmonary, gastrointestinal, endocrine, neurological (including epilepsy), infectious, neoplastic, or metabolic disturbance (if there is a history of such disease but the condition has been stable for at least one year and is judged by the investigator not to render inclusion unsafe and not to interfere with the patient's participation in the study, the patient may be included.)
Beschrijving

Illness Serious | Illness Sequelae Serious | Hepatic Insufficiency | Renal Insufficiency | Cardiovascular Disease | Lung disease | Gastrointestinal Disease | Endocrine System Disease | Nervous system disorder | Epilepsy | Communicable Disease | Neoplastic disease | Metabolic Disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0243088
UMLS CUI [2,3]
C0205404
UMLS CUI [3]
C1306571
UMLS CUI [4]
C1565489
UMLS CUI [5]
C0007222
UMLS CUI [6]
C0024115
UMLS CUI [7]
C0017178
UMLS CUI [8]
C0014130
UMLS CUI [9]
C0027765
UMLS CUI [10]
C0014544
UMLS CUI [11]
C0009450
UMLS CUI [12]
C1882062
UMLS CUI [13]
C0025517
Terug naar het begin van de pagina

Similar models

Eligibility Postpartum Depression NCT01527474

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
female between the ages of 19 to 40 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Birth Recently
Item
given birth in the last 6 months
boolean
C0005615 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Breast Feeding Absent
Item
not currently breastfeeding
boolean
C0006147 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Major Depressive Disorder
Item
meet criteria for major depressive disorder as per the diagnostic and statistical manual of mental disorders, 4th edition (dsm-iv tr)
boolean
C1269683 (UMLS CUI [1])
Montgomery-Asberg Depression Rating Scale Questionnaire
Item
montgomery-asberg depression rating scale (madrs) score greater than or equal to 25 at enrolment
boolean
C4054475 (UMLS CUI [1])
Able to read English Language | Able to write English Language
Item
able to read and write english
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Informed Consent
Item
sign written informed consent to participate in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
At risk for suicide | Feeling suicidal MADRS
Item
have a significant risk of suicide according to the investigator's opinion or presents a score of 5 or greater on item 10 (suicidal thoughts) of of the madrs
boolean
C0563664 (UMLS CUI [1])
C0424000 (UMLS CUI [2,1])
C4054475 (UMLS CUI [2,2])
Manic episode | Hypomanic episode | Psychotic symptom | Psychotic Disorders | Substance Use Disorders | Substance Dependence
Item
meets dsm-iv-tr criteria for past or current manic or hypomanic episode, past or current psychotic symptoms or disorder, and/or has a history of drug or alcohol abuse/dependence within the last 6 months
boolean
C0349208 (UMLS CUI [1])
C1396834 (UMLS CUI [2])
C0871189 (UMLS CUI [3])
C0033975 (UMLS CUI [4])
C0038586 (UMLS CUI [5])
C0038580 (UMLS CUI [6])
Antidepressive Agents | Fluoxetine | Benzodiazepines | Anti-Anxiety Agents | Sedative hypnotics (non-benzodiazepines) | Antipsychotic Agents Oral | Antipsychotic Agents Depot | Serotonin Agents | Triptans | Tryptophan | Tramadol | Herbal medicine Psychoactive | ST. JOHN'S WORT EXTRACT | Kava preparation | Valerian | Ginkgo biloba extract | Psychotropic Drugs | Anticonvulsants | Investigational New Drugs
Item
uses the following disallowed recent or concomitant medication within the specified time periods - any antidepressant or any drug used for augmentation of antidepressant action within the last 2 weeks (5 weeks for fluoxetine) prior to baseline, any benzodiazepines or other anxiolytics within the last week prior to baseline, any non-benzodiazepine hypnotics within the last week prior to baseline, oral antipsychotics within 2 weeks or depot antipsychotics within 6 months prior to baseline, serotonergic medicinal products (for example triptans, tryptophan, tramadol) within the last week prior to baseline, psychoactive herbal remedies (for example st. johns wort, kava kava, valerian, gingko biloba) within the last 2 weeks prior to baseline, any other drug with potential psychotropic effects within the last 2 weeks prior to baseline, any anticonvulsant drug within the last 2 weeks prior to baseline, or any investigational product within 3 months prior to baseline
boolean
C0003289 (UMLS CUI [1])
C0016365 (UMLS CUI [2])
C0005064 (UMLS CUI [3])
C0040616 (UMLS CUI [4])
C3854290 (UMLS CUI [5])
C0040615 (UMLS CUI [6,1])
C1527415 (UMLS CUI [6,2])
C0040615 (UMLS CUI [7,1])
C0086129 (UMLS CUI [7,2])
C0242701 (UMLS CUI [8])
C1567966 (UMLS CUI [9])
C0041249 (UMLS CUI [10])
C0040610 (UMLS CUI [11])
C2240391 (UMLS CUI [12,1])
C0682880 (UMLS CUI [12,2])
C0813171 (UMLS CUI [13])
C0939882 (UMLS CUI [14])
C0795674 (UMLS CUI [15])
C0772125 (UMLS CUI [16])
C0033978 (UMLS CUI [17])
C0003286 (UMLS CUI [18])
C0013230 (UMLS CUI [19])
Cognitive Therapy | Behavior Therapy | Psychotherapy systematic | Cognitive Therapy Planned | Behavior Therapy Planned | Psychotherapy systematic Planned
Item
is currently receiving formal cognitive or behavioural therapy, systematic psychotherapy, or plans to initiate such therapy during the study
boolean
C0009244 (UMLS CUI [1])
C0004933 (UMLS CUI [2])
C0033968 (UMLS CUI [3,1])
C0220922 (UMLS CUI [3,2])
C0009244 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
C0004933 (UMLS CUI [5,1])
C1301732 (UMLS CUI [5,2])
C0033968 (UMLS CUI [6,1])
C0220922 (UMLS CUI [6,2])
C1301732 (UMLS CUI [6,3])
Depressive Symptoms | Resistant to Antidepressant therapy Quantity
Item
current depressive symptoms of the patient are considered by the investigator to have been resistant to two well-conducted antidepressant treatments of at least 6 weeks duration
boolean
C0086132 (UMLS CUI [1])
C0332325 (UMLS CUI [2,1])
C1096649 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Illness Serious | Illness Sequelae Serious | Hepatic Insufficiency | Renal Insufficiency | Cardiovascular Disease | Lung disease | Gastrointestinal Disease | Endocrine System Disease | Nervous system disorder | Epilepsy | Communicable Disease | Neoplastic disease | Metabolic Disease
Item
has a serious illness or serious sequelae thereof, including liver or renal insufficiency, or a cardiovascular, pulmonary, gastrointestinal, endocrine, neurological (including epilepsy), infectious, neoplastic, or metabolic disturbance (if there is a history of such disease but the condition has been stable for at least one year and is judged by the investigator not to render inclusion unsafe and not to interfere with the patient's participation in the study, the patient may be included.)
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0243088 (UMLS CUI [2,2])
C0205404 (UMLS CUI [2,3])
C1306571 (UMLS CUI [3])
C1565489 (UMLS CUI [4])
C0007222 (UMLS CUI [5])
C0024115 (UMLS CUI [6])
C0017178 (UMLS CUI [7])
C0014130 (UMLS CUI [8])
C0027765 (UMLS CUI [9])
C0014544 (UMLS CUI [10])
C0009450 (UMLS CUI [11])
C1882062 (UMLS CUI [12])
C0025517 (UMLS CUI [13])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial